FDA Brief

Company record

ImprimisRx NJ

1 FDA warning letter since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about ImprimisRx NJ.

Warning letters

  1. ImprimisRx NJ

    Compounding Pharmacy/Adulterated Drug Products

Recalls

ReportedClassFirmProduct and reason
Sep 16 Class III ImprimisRx NJ LLC
Drug
Povidone Iodine 1.25% / Proparacaine HCl 0.5% Ophthalmic Solution, 10 mL per dropper bottle, For Office Use Only, Imprimis NJOF, LLC, 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-732-10
Subpotent Drug